Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 1/20 | 0.78 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.78 |
| ▸ | MAPT | P10636 | 1/20 | 0.75 |
| ▸ | BLM | P54132 | 1/20 | 0.75 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.59 |
| ▸ | CHRM5 | P08912 | 6/20 | 0.58 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.58 |
| ▸ | CHRM3 | P20309 | 6/20 | 0.58 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.58 |
| ▸ | CHRM4 | P08173 | 5/20 | 0.58 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.58 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.58 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.58 |
| ▸ | HTR1A | P08908 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | PGR | P06401 | 1/20 | 0.58 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.58 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.58 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.58 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL15994023 | 0.98 | ADRA2A (0.75) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| SCHEMBL30511986 | 0.98 | ADRA2A (0.75) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Fluoride Ion SCHEMBL15993972 | 0.98 | ADRA2A (0.75) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Hydrochloric Acid SCHEMBL316716 | 0.98 | MAPT (0.79) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Hydrochloric Acid SCHEMBL19025642 | 0.98 | ADRA2A (0.75) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Iodide SCHEMBL1157377 | 0.98 | ADRA2A (0.75) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Bromide SCHEMBL8614700 | 0.98 | ADRA2A (0.75) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Bicarbonate SCHEMBL15993908 | 0.92 | ADRA2A (0.67) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Suxamethonium SCHEMBL41537 | 0.88 | ADRA2A (1.00) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Iodide SCHEMBL28412164 | 0.87 | ADRA2A (0.60) | ADRA2AADRA1AMAPTBLMCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1051 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026101809-A1 | MOLYBDENUM LINER DEPOSITION | LAM RESEARCH CORPORATION (US) | 2026-05-15 | — | — | WO | claimed |
| WO-2026090013-A1 | ETCHING OF MOLYBDENUM | LAM RESEARCH CORPORATION (US) | 2026-04-30 | — | — | WO | claimed |
| US-12559735-B2 | Device for detecting organophosphates | PLANTVAX, INC. (US) | 2026-02-24 | — | — | US | claimed |
| WO-2025264794-A1 | RESIDUE REMOVAL AFTER ETCH PROCESSES USING A BORON-CONTAINING ETCHANT | APPLIED MATERIALS, INC. (US) | 2025-12-26 | — | — | WO | claimed |
| CN-119913767-A | Method for extracting cellulose from biomass raw material | 中国石油化工股份有限公司 | 2025-05-02 | — | — | CN | claimed |
| WO-2025064257-A1 | METAL-CONTAINING HARDMASK OPENING METHODS USING BORON-AND-HALOGEN-CONTAINING PRECURSORS | APPLIED MATERIALS, INC. (US) | 2025-03-27 | — | — | WO | claimed |
| US-12257566-B2 | Carbon dioxide absorbent including phenolate-based ionic liquid and aliphatic alcohol and method of separating carbon dioxide using the same | SK INNOVATION CO., LTD. (KR) | 2025-03-25 | — | — | US | claimed |
| US-12239616-B2 | Food supplement and composition comprising choline butyrate salt and/or butyrylcholine | ABERGAVENNY NV (BE) | 2025-03-04 | — | — | US | claimed |
| WO-2025021779-A1 | VAPOR-PHASE THERMAL ETCH OF METAL OXIDES | MERCK PATENT GMBH (DE) | 2025-01-30 | — | — | WO | claimed |
| US-20250001390-A1 | Carbon Dioxide Absorbent Including Phenolate-Based Ionic Liquid and Aliphatic Alcohol and Method of Separating Carbon Dioxide Using the Same | SK INNOVATION CO., LTD. (KR) | 2025-01-02 | — | — | US | claimed |
| WO-2001085985-A1 | ASSAY FOR DETECTING, MEASURING AND MONITORING THE ACTIVITIES AND CONCENTRATIONS OF PROTEINS AND METHODS OF USE THEREOF | UNITED STATES ARMY MEDICAL RESEARCH AND MATERIAL COMMAND (US) | 2001-11-15 | — | — | WO | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| EP-0674232-B1 | Recording sheets | XEROX CORP (US) | 2000-05-31 | — | — | EP | claimed |
| EP-0674233-B1 | Recording sheets | XEROX CORP (US) | 2000-05-24 | — | — | EP | claimed |
| WO-1997021737-A1 | PHOTOINITIATOR COMPOSITION CONTAINING A BORATE SALT AND A HYPERVALENT ATOM-CONTAINING SALT | SPECTRA GROUP LIMITED, INC. (US) | 1997-06-19 | — | — | WO | claimed |
| EP-0315782-B1 | Method for the production of proteins | THOMAE GMBH DR K (DE) | 1994-09-28 | — | — | EP | claimed |
| EP-0591472-A1 | EXPRESSION OF ENZYMATICALLY ACTIVE RECOMBINANT HUMAN ACETYLCHOLINESTERASE AND USES THEREOF | BIO-TECHNOLOGY GENERAL CORPORATION (US) | 1994-04-13 | — | — | EP | claimed |
| WO-1993001830-A1 | EXPRESSION OF ENZYMATICALLY ACTIVE RECOMBINANT HUMAN ACETYLCHOLINESTERASE AND USES THEREOF | BIO-TECHNOLOGY GENERAL CORP. (US) | 1993-02-04 | — | — | WO | claimed |
| EP-0464388-A1 | Detection assays having chromogenic and nonchromogenic, hypocromogenic, bathochromogenic or hypsochromogenic substrates | TECHNICON INSTRUMENTS CORPORATION (a New York corporation) (US) | 1992-01-08 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559735-B2 | Device for detecting organophosphates | BCHE, LIPE, ACHE | ADRA2A 3306/4885ADRA1A 3101/4885MAPT 3814/4885 |
| US-12239616-B2 | Food supplement and composition comprising choline butyrate salt and/or butyrylcholine | SLC10A2, CHAT, BCHE | ADRA2A 1650/4885ADRA1A 1750/4885MAPT 942/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.